Assessing the meaningful change threshold of quality of life in depression scale using data from two phase 3 studies of esketamine nasal spray

HIGHLIGHTS

• who: Heather Rozjabek from the (UNIVERSITY) have published the paper: Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray, in the Journal: (JOURNAL) of February/01,/2017
• what: The aim of this analysis was to determine the within-patient MCT of the self-reported Quality-of-Life in Depression Scale (QLDS) among patients with MDD and active suicidal ideation with intent (MDSI) using an anchor-based approach.
• how: Although the MCT can be determined using either an anchor-based . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.